PTC Therapeutics
PTCT
#3029
Rank
A$7.49 B
Marketcap
A$90.38
Share price
0.14%
Change (1 day)
16.63%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: A$7.49 Billion

As of May 2026 PTC Therapeutics has a market cap of A$7.49 Billion. This makes PTC Therapeutics the world's 3029th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$7.49 B-20.42%
2025A$9.41 B67.91%
2024A$5.60 B83.72%
2023A$3.05 B-25.42%
2022A$4.09 B5.39%
2021A$3.88 B-28.28%
2020A$5.41 B27.47%
2019A$4.24 B72.34%
2018A$2.46 B178.12%
2017A$0.88 B70.66%
2016A$0.51 B-65.57%
2015A$1.50 B-27.52%
2014A$2.08 B359.54%
2013A$0.45 B

End of Day market cap according to different sources

On May 2nd, 2026 the market cap of PTC Therapeutics was reported to be:

A$7.49 Billion
by Nasdaq info icon info icon
A$7.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$387.98 B 5,077.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$149.59 B 1,896.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.30 B-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.14 B-58.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.24 B-96.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$15.60 B 108.25%๐Ÿ‡บ๐Ÿ‡ธ USA